BIOTECanada

Looking to connect with leaders in the #biotech industry? BIOTECanada can help. 🤝 Our flagship publication, Insights Magazine, is a strategic and timely resource for keeping key audiences informed about important developments within the biotech sector. Published semi-annually, Insights reaches a wide array of readers across North America, including industry CEOs, senior leaders, policymakers at federal and provincial levels, media, and influential thought leaders. The fall 2024 issue of Insights will showcase the expansive growth of Canada’s biotechnology sector, emphasizing advancements in AI, CRISPR, and biomanufacturing, alongside the strategic roles of investment and policy. We will also explore how Canada is enhancing its regulatory capacity to support innovation and attract global pharmaceutical and biotech industries, bolstering its stance as a global leader in biotech. This issue will also highlight how these efforts are positioning Canada at the forefront of a transformative phase in healthcare, benefiting both national and global communities. The media kit for the Fall 2024 issue is now available. View it here: https://lnkd.in/eDJgp5wu Read the latest issue of Insights here: https://lnkd.in/gr98FyJz

🚨 Reminder: CMIE Development Fund's Second Call for Proposals - Deadline Approaching! 🚨 The submission deadline for the CMIE Development Fund's Second Call for Proposal is just over a month away: August 20, 2024, at 11:59pm PST. Submit a brief, non-confidential PowerPoint presentation using the template provided in the link below. Don't miss this opportunity to secure funding for your medical isotope project! To learn more, please visit our website: https://lnkd.in/e4iu8su6   #FundingOpportunity #Innovation #CMIEDF

Thrilled to welcome BioTalent Canada as our newest BIONATION builder. BIONATION will take place in Ottawa on September 24-25, featuring keynote speakers and panels that will explore the sector's capacity. The event will focus on the investment and talent essential for the next generation of sector growth, and will identify the federal policy alignments needed for the future. Learn more about BioTalent here: https://www.biotalent.ca/ Read more about BIONATION here: https://lnkd.in/enwkR9A2 #biotechnology #ecosystem #biotech #canada #innovation #publicpolicy #cdnpoli #bionation2024 #BIONATIONBuilder Nous sommes enchantés d’accueillir BIOTALENT au rang de nos bâtisseurs BIONATION. Présenté les 24 et 25 septembre à Ottawa, BIONATION regroupera des conférences et des panels explorant les capacités du secteur canadien des biotechnologies. L’événement se concentrera sur les investissements et les talents nécessaires à la prochaine phase de croissance du secteur, et les politiques publiques requises pour assurer son avenir. Apprenez-en plus sur BioTalent ici : https://www.biotalent.ca/ Apprenez-en plus sur BIONATION ici : https://lnkd.in/enwkR9A2

BIOTECanada welcomes the announcement that the Government of Canada has entered into a bilateral agreement with the province of British Columbia which will improve access to drugs for rare diseases, early diagnosis, and screening for British Columbian rare disease patients. More broadly, the bilateral agreement is an important and meaningful step in the implementation of the National Strategy for Rare Diseases established by the federal government to provide Canadian patients with rare diseases greater access to important new therapies and technologies. Many Canadian biotechnology companies are developing drugs for rare diseases. In addition, numerous global biotech companies have developed and are bringing to Canada remarkable new drugs and therapeutics to address the healthcare needs of patients with rare diseases. In this context, while BIOTECanada welcomes the bilateral agreement, the industry encourages the federal and provincial governments to continue working with patient groups and the industry to enhance the transparency of the process and the development of real-world evidence to inform subsequent decisions regarding drugs for rare disease. A collaborative and transparent implementation process for the National Strategy will ensure Canadians living with rare disease have timely access to innovative and life-saving treatments. #rarediseases #canada

A strong endorsement of the vitality and potential of the Canadian biotech industry, promising to bring enhanced capabilities, economic benefits, and further innovation to the sector. Congratulations to the BIOVECTRA team!

A special welcome to Centre for Probe Development and Commercialization (CPDC) as they join BIOTECanada's 240 members representing the full biotechnology ecosystem and all life sciences sectors including healthcare, academia, biomanufacturing, and investment. CPDC is a not-for-profit corporation founded in 2008 to advance probe (chemical agents that will carry medical isotopes to targets in the body) discovery, development, and clinical research, and provide a reliable supply of radiopharmaceuticals. CPDC’s mission is to improve the quality of Canadian patients’ lives through the commercialization of advanced research and the clinical development of nuclear medicine. In the past 15 years, CPDC has created four Canadian commercial entities that have advanced the availability of radiopharmaceuticals to the Canadian medical community. CPDC’s self-funding business model will continue to identify and advance critical radiopharmaceuticals to meet the needs of Canadian patients and physicians through collaboration with partners including industry, academia, and government. Read more about CPDC here: https://cpdc.ca/ For BIOTECanada’s full membership listing, visit: https://lnkd.in/dvc8X94n #newmember #innovation #nuclearmedicine #Ontario #radiopharmaceuticals

A warm welcome SaNOtize Research and Development Corp. as they join BIOTECanada's membership! SaNOtize, based in Vancouver, Canada, is developing and commercializing products that deliver the natural antimicrobial properties of nitric oxide (NO) for use in common viral, bacterial, and fungal infections. SaNOtize was co-founded in 2017 by Gilly Regev, PhD, a biochemist, and Chris Miller, PhD, a longtime leader in the NO field. Together they developed a novel delivery system for NO, enabling it to be used for the first time as a topical antimicrobial. Read more about SaNOtize here: https://sanotize.com/ For BIOTECanada’s full membership listing, visit: https://lnkd.in/dvc8X94n #newmember #Vancouver #innovation #biotech #Canada #ecosystem #nitricoxide

BIOTECanada warmly welcomes SeraGene Therapeutics to our diverse network of over 240 members. As the newest member, SeraGene Therapeutics joins a robust ecosystem spanning healthcare, academia, biomanufacturing, and investment within the biotechnology ecosystem. SeraGene Therapeutics is addressing limitations in current care standards for #coagulation disorders by delivering innovative therapies that provide long-lasting control over disordered coagulation. Designed with life-long use in mind, they have selected high efficacy targets with a lower potential safety risk to meaningfully improve the quality of life for those living with coagulation disorders. Their technology provides proprietary #RNA agents with liver-targeting drug delivery vehicles to restore #hemostasis by precisely modulating the endogenous expression of clotting proteins in the blood. Read more about SeraGene Therapeutics here: For BIOTECanada’s full membership listing, visit: https://lnkd.in/dvc8X94n #newmember #ecosystem #biotechnology #canada #Vancouver #BC #innovation

Excited to celebrate BIOTECanada member Aspect Biosystems and the Governments of Canada and British Columbia on their groundbreaking $200 million investment in bioprinted tissue therapeutics. This initiative not only propels Aspect Biosystems to the forefront of regenerative medicine, but also strengthens Canada's global leadership in biotechnology. Congratulations to Tamer Mohamed and the Aspect team for leading this innovative charge, demonstrating the power of collaboration in enhancing healthcare and economic growth. #Biotech #Innovation #CanadianBiotech #Healthcare #RegenerativeMedicine

Happy #CanadaDay! 🍁 As we celebrate our nation’s heritage, we also applaud the remarkable achievements of the Canadian biotech industry, especially the work of our #BIOTECanada members. This past year has been monumental, highlighted by our strong presence at #BIO2024, where the #Canada Pavilion showcased our commitment to global #biotech leadership. Our vibrant ecosystem, characterized by collaboration across academia, industry, and government, drives us forward, setting the stage for future breakthroughs like next-generation vaccines and novel gene-editing tools. Let’s continue to lead the transformation of healthcare globally. Here’s to Canada's continued success, propelling us toward a future where we exceed the possibilities of biotech. Watch our throwback to the opening of the Canada Pavilion at BIO in June: